Manchester Metropolitan University's Research Repository

    Items where Author is "Aballéa, Samuel"

    Up a level
    Export as [feed] Atom [feed] RSS
    Group by: Item Type | No Grouping
    Jump to: Article
    Number of items: 3.


    (2023) Cost‐effectiveness of recombinant factor VIII Fc versus emicizumab for prophylaxis in adults and adolescents with haemophilia A without inhibitors in the UK. European Journal of Haematology, 110 (3). pp. 262-270. ISSN 0902-4441

    (2022) Cost-minimization analysis of recombinant factor VIII Fc versus emicizumab for treating patients with hemophilia A without inhibitors in Europe. Journal of Medical Economics, 25 (1). pp. 1068-1075. ISSN 1369-6998

    Pasi, John ORCID logoORCID: https://orcid.org/0000-0003-3394-2099, Hermans, Cédric ORCID logoORCID: https://orcid.org/0000-0001-5429-8437, Hakimi, Zalmai, Nazir, Jameel, Aballéa, Samuel, Ezzalfani, Monia and Fatoye, Francis ORCID logoORCID: https://orcid.org/0000-0002-3502-3953 (2022) Improvement in pain-related quality of life in patients with hemophilia A treated with rFVIIIFc individualized prophylaxis: post hoc analysis from the A-LONG study. Therapeutic Advances in Hematology, 13. pp. 1-9. ISSN 2040-6207

    This list was generated on Fri Jul 12 05:55:13 2024 BST.